Literature DB >> 28356277

Validation of spot urine in predicting 24-h sodium excretion at the individual level.

Long Zhou1, Yu Tian1,2, Jun-Jie Fu3, Ying-Ying Jiang4, Ya-Min Bai4, Zi-Hua Zhang5, Xiao-He Hu5, Hong-Wu Lian5, Min Guo1, Zheng-Xiong Yang6, Lian-Cheng Zhao7.   

Abstract

Background: Evidence for the effect of dietary sodium intake on the risk of cardiovascular disease has been controversial. One of the main explanations for the conflicting results lies in the great variability associated with measurement methods for sodium intake. Spot urine collection is a convenient method commonly used for sodium estimation, but its validity for predicting 24-h urinary sodium excretion at the individual level has not been well evaluated among the general population.Objective: The aim of this study was to evaluate the validity of the Kawasaki, the International Cooperative Study on Salt, Other Factors, and Blood Pressure (INTERSALT), and the Tanaka formulas in predicting 24-h urinary sodium excretion by using spot urine samples in Chinese adults.Design: We analyzed the relative and absolute differences and misclassification at the individual level from 3 commonly used methods for estimating sodium intake among 141 Chinese community residents.
Results: The mean measured 24-h sodium excretion was 220.8 mmol/d. The median (95% CIs) differences between measured sodium and those estimated from the Kawasaki, INTERSALT, and Tanaka methods were 6.4 mmol/d (-17.5, 36.8 mmol/d), -67.3 mmol/d (-96.5, -46.9 mmol/d), and -42.9 mmol/d (-59.1, -24.8 mmol/d), respectively. The proportions of relative differences >40% with the Kawasaki, INTERSALT, and Tanaka methods were 31.2%, 41.1%, and 22.0%, respectively; and the absolute difference for the 3 methods was >51.3 mmol/d (3 g salt) in approximately half of the participants. The misclassification rate was 63.1% for the Kawasaki method, 78.7% for the INTERSALT method, and 66.0% for the Tanaka method at the individual level.
Conclusion: The results from our study do not support the use of spot urine to estimate 24-h urinary sodium excretion at the individual level because of its poor performance with respect to misclassification. This trial was registered at www.chictr.org.cn as ChiCTR-IOR-16010278.
© 2017 American Society for Nutrition.

Entities:  

Keywords:  24-hour urine; formula; sodium intake; spot urine; validation

Mesh:

Substances:

Year:  2017        PMID: 28356277     DOI: 10.3945/ajcn.116.147553

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  22 in total

1.  Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health.

Authors:  Feng J He; Norm R C Campbell; Yuan Ma; Graham A MacGregor; Mary E Cogswell; Nancy R Cook
Journal:  Int J Epidemiol       Date:  2018-12-01       Impact factor: 7.196

2.  Validity of predictive equations for 24-h urinary potassium excretion based on timing of spot urine collection among adults: the MESA and CARDIA Urinary Sodium Study and NHANES Urinary Sodium Calibration Study.

Authors:  Carla I Mercado; Mary E Cogswell; Catherine M Loria; Kiang Liu; Norrina Allen; Cathleen Gillespie; Chia-Yih Wang; Ian H de Boer; Jacqueline Wright
Journal:  Am J Clin Nutr       Date:  2018-09-01       Impact factor: 7.045

3.  Salt intake and prevalence of overweight/obesity in Japan, China, the United Kingdom, and the United States: the INTERMAP Study.

Authors:  Long Zhou; Jeremiah Stamler; Queenie Chan; Linda Van Horn; Martha L Daviglus; Alan R Dyer; Katsuyuki Miura; Nagako Okuda; Yangfeng Wu; Hirotsugu Ueshima; Paul Elliott; Liancheng Zhao
Journal:  Am J Clin Nutr       Date:  2019-07-01       Impact factor: 7.045

4.  Agreement between 24-h dietary recalls and 24-h urine collections for estimating sodium intake in China, Japan, UK, USA: the International Study of Macro- and Micro-nutrients and Blood Pressure.

Authors:  Xiaoxiao Wen; Long Zhou; Jeremiah Stamler; Queenie Chan; Linda Van Horn; Martha L Daviglus; Alan R Dyer; Paul Elliott; Hirotsugu Ueshima; Katsuyuki Miura; Nagako Okuda; Yangfeng Wu; Liancheng Zhao
Journal:  J Hypertens       Date:  2019-04       Impact factor: 4.844

5.  People with the major alleles of ATP2B1 rs17249754 increases the risk of hypertension in high ratio of sodium and potassium, and low calcium intakes.

Authors:  J W Daily; B C Kim; M Liu; S Park
Journal:  J Hum Hypertens       Date:  2017-09-21       Impact factor: 3.012

6.  Skin sodium is increased in male patients with multiple sclerosis and related animal models.

Authors:  Konstantin Huhn; Peter Linz; Franziska Pemsel; Bernhard Michalke; Stefan Seyferth; Christoph Kopp; Mohammad Anwar Chaudri; Veit Rothhammer; Arnd Dörfler; Michael Uder; Armin M Nagel; Dominik N Müller; Anne Waschbisch; De-Hyung Lee; Tobias Bäuerle; Ralf A Linker; Stefanie Haase
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

7.  A New Method to Estimate Dietary Sodium Intake From a Spot Urine Sample: Context and Caution.

Authors:  Matthew J Belanger; Michael K Lorinsky; Varayini Pankayatselvan; Stephen P Juraschek
Journal:  Am J Hypertens       Date:  2021-08-09       Impact factor: 3.080

8.  Association of Salt-Reduction Knowledge and Behaviors and Salt Intake in Chinese Population.

Authors:  Bing Han; Chuancang Li; Yabing Zhou; Mengge Zhang; Yang Zhao; Ting Zhao; Dongsheng Hu; Liang Sun
Journal:  Front Public Health       Date:  2022-04-18

9.  A Cross-Sectional Study on the Association between 24-h Urine Osmolality and Weight Status in Older Adults.

Authors:  Patrícia Padrão; Ana S Sousa; Rita S Guerra; Luísa Álvares; Alejandro Santos; Nuno Borges; Cláudia Afonso; Teresa F Amaral; Pedro Moreira
Journal:  Nutrients       Date:  2017-11-22       Impact factor: 5.717

10.  Twenty-Four-Hour Urinary Sodium and Potassium Excretion in China: A Systematic Review and Meta-Analysis.

Authors:  Monique Tan; Feng J He; Changqiong Wang; Graham A MacGregor
Journal:  J Am Heart Assoc       Date:  2019-07-11       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.